Abstract: The Use of Nanofat in Androgenic Alopecia. a Prospective Blinded Study

METHODS: We enrolled 12 consecutive male patients affected with androgenic alopecia at our private practice. Patients were excluded if they were or had been under treatment with oral finasteride or laser or injectable treatment for hair regrowth in the previous 6 months. Patients under topical minoxidil (2% or 5%) were given a wash out period of 60 days. Each patient was given a single injection session of nanofat, following the microbolus technique over the interested areas of the scalp. One area was selected as control and was not treated. The nanofat was obtained from the liposuction aspirate using the Tulip NanoTM kit device and immediately after it was injected in the treated scalp area. Each patient underwent trichoscopy of the sample marked area and a thricogram examination at baseline, and then 1, 3, 6 and 12 months after treatment by a blinded physician. A patient satisfaction VAS score was also recorded at the post-treatment visits. Adverse events were recorded at each follow up.